Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral neutralizing activity.
Iwamoto N, Takamatsu Y, Asai Y, Tsuchiya K, Matsuda K, Oshiro Y, Inamura N, Terada M, Nemoto T, Kimura M, Saito S, Morioka S, Kenji M, Mitsuya H, Ohmagari N. Iwamoto N, et al. Among authors: tsuchiya k. Heliyon. 2024 Jan 13;10(2):e24513. doi: 10.1016/j.heliyon.2024.e24513. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38304834 Free PMC article.
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition.
Maeda K, Das D, Yin PD, Tsuchiya K, Ogata-Aoki H, Nakata H, Norman RB, Hackney LA, Takaoka Y, Mitsuya H. Maeda K, et al. Among authors: tsuchiya k. J Mol Biol. 2008 Sep 12;381(4):956-74. doi: 10.1016/j.jmb.2008.06.041. Epub 2008 Jun 20. J Mol Biol. 2008. PMID: 18590744 Free PMC article.
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.
Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M. Sugiyama M, et al. Among authors: tsuchiya k. Gene. 2021 Jan 15;766:145145. doi: 10.1016/j.gene.2020.145145. Epub 2020 Sep 14. Gene. 2021. PMID: 32941953 Free PMC article.
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Matsuda K, Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, Mitsuya H. Maeda K, et al. Among authors: tsuchiya k. Sci Rep. 2021 Mar 10;11(1):5563. doi: 10.1038/s41598-021-84733-5. Sci Rep. 2021. PMID: 33692457 Free PMC article.
A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators.
Matsuda K, Kobayakawa T, Kariya R, Tsuchiya K, Ryu S, Tsuji K, Ishii T, Gatanaga H, Yoshimura K, Okada S, Hamada A, Mitsuya H, Tamamura H, Maeda K. Matsuda K, et al. Among authors: tsuchiya k. Front Microbiol. 2021 Mar 17;12:636276. doi: 10.3389/fmicb.2021.636276. eCollection 2021. Front Microbiol. 2021. PMID: 33815322 Free PMC article.
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. Inada M, et al. Among authors: tsuchiya k. J Infect Chemother. 2021 Jul;27(7):1063-1067. doi: 10.1016/j.jiac.2021.04.017. Epub 2021 Apr 24. J Infect Chemother. 2021. PMID: 33962861 Free PMC article.
Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals.
Maeda K, Amano M, Uemura Y, Tsuchiya K, Matsushima T, Noda K, Shimizu Y, Fujiwara A, Takamatsu Y, Ichikawa Y, Nishimura H, Kinoshita M, Matsumoto S, Gatanaga H, Yoshimura K, Oka SI, Mikami A, Sugiura W, Sato T, Yoshida T, Shimada S, Mitsuya H. Maeda K, et al. Among authors: tsuchiya k. Sci Rep. 2021 Nov 24;11(1):22848. doi: 10.1038/s41598-021-01930-y. Sci Rep. 2021. PMID: 34819514 Free PMC article.
A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro.
Matsuda K, Islam S, Takada T, Tsuchiya K, Yang Tan BJ, Hattori SI, Katsuya H, Kitagawa K, Kim KS, Matsuo M, Sugata K, Delino NS, Gatanaga H, Yoshimura K, Matsushita S, Mitsuya H, Iwami S, Satou Y, Maeda K. Matsuda K, et al. Among authors: tsuchiya k. Cell Rep Methods. 2021 Nov 29;1(8):100122. doi: 10.1016/j.crmeth.2021.100122. eCollection 2021 Dec 20. Cell Rep Methods. 2021. PMID: 35475215 Free PMC article.
3,070 results